WOOJUNG BIO Inc (215380) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.033x

Based on the latest financial reports, WOOJUNG BIO Inc (215380) has a cash flow conversion efficiency ratio of -0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-809.75 Million ≈ $-548.76K USD) by net assets (₩24.58 Billion ≈ $16.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See WOOJUNG BIO Inc balance sheet independence to measure how much of total assets are equity-financed.

WOOJUNG BIO Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how WOOJUNG BIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check WOOJUNG BIO Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

WOOJUNG BIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of WOOJUNG BIO Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
The Steel Public Company Limited BK:THE	0.156x
Avecho Biotechnology Limited F:OEZ	-0.128x
Gurktaler AG ST VI:GAGS	-0.006x
Duc Long Gia Lai Group JSC VN:DLG	-0.523x
rYojbaba Co., Ltd. Common Shares NASDAQ:RYOJ	0.000x
Flexiroam Ltd AU:FRX	-0.898x
Galil Capital Re Spain SOCIMI SA MC:YGCS	-0.034x
Equippp Social Impact Technologies Limited NSE:EQUIPPP	0.009x

Annual Cash Flow Conversion Efficiency for WOOJUNG BIO Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of WOOJUNG BIO Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of WOOJUNG BIO Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩29.37 Billion ≈ $19.91 Million	₩-1.13 Billion ≈ $-763.37K	-0.038x	+73.85%
2023-12-31	₩21.97 Billion ≈ $14.89 Million	₩-3.22 Billion ≈ $-2.18 Million	-0.147x	-274.16%
2022-12-31	₩29.72 Billion ≈ $20.14 Million	₩2.50 Billion ≈ $1.70 Million	0.084x	+53.31%
2021-12-31	₩31.46 Billion ≈ $21.32 Million	₩1.73 Billion ≈ $1.17 Million	0.055x	+117.95%
2020-12-31	₩28.03 Billion ≈ $19.00 Million	₩-8.57 Billion ≈ $-5.81 Million	-0.306x	-4007.26%
2019-12-31	₩26.66 Billion ≈ $18.07 Million	₩208.72 Million ≈ $141.45K	0.008x	+134.30%
2018-12-31	₩21.20 Billion ≈ $14.37 Million	₩-483.80 Million ≈ $-327.87K	-0.023x	+82.39%
2017-12-31	₩18.32 Billion ≈ $12.42 Million	₩-2.38 Billion ≈ $-1.61 Million	-0.130x	+5.85%
2016-12-31	₩10.57 Billion ≈ $7.16 Million	₩-1.46 Billion ≈ $-986.04K	-0.138x	--

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$25.76 Million

₩38.01 Billion KRW

Market Cap Rank

#24236 Global

#1692 in Korea

Share Price

₩2280.00

Change (1 day)

+0.00%

52-Week Range

₩1590.00 - ₩3605.00

All Time High

₩13450.00